Northwest & Ethical Investments L.P. Profound Medical Corp. Transaction History
Northwest & Ethical Investments L.P.
- $4.24 Trillion
- Q3 2025
A detailed history of Northwest & Ethical Investments L.P. transactions in Profound Medical Corp. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 38,200 shares of PROF stock, worth $254,794. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,200
Previous 46,200
17.32%
Holding current value
$254,794
Previous $274 Million
31.91%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding PROF
# of Institutions
45Shares Held
11.2MCall Options Held
0Put Options Held
0-
Fil LTD Hamilton, D01.89MShares$12.6 Million0.01% of portfolio
-
Gagnon Securities LLC1.73MShares$11.6 Million1.88% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A8986KShares$6.58 Million0.09% of portfolio
-
Gagnon Advisors, LLC897KShares$5.98 Million3.07% of portfolio
-
Royce & Associates LP860KShares$5.74 Million0.05% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $139M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...